Kukje Pharma Co., Ltd. (002720.KS)
KRW 4970.0
(-2.17%)
KRW 4970.0
(-2.17%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -415.49 KRW | -336.64% |
| 2022 | 175.58 KRW | 328.71% |
| 2021 | -76.77 KRW | -174.17% |
| 2020 | 103.50 KRW | 144.06% |
| 2019 | -234.89 KRW | -317.35% |
| 2018 | 108.07 KRW | 99.39% |
| 2017 | 54.20 KRW | 44.69% |
| 2016 | 37.46 KRW | 112.81% |
| 2015 | -292.38 KRW | 15.66% |
| 2014 | -346.67 KRW | -425.94% |
| 2013 | 106.36 KRW | 111.23% |
| 2012 | -947.30 KRW | -2132.4% |
| 2011 | 46.61 KRW | -79.71% |
| 2010 | 229.75 KRW | -37.68% |
| 2009 | 368.66 KRW | -1.07% |
| 2008 | 372.64 KRW | 8.67% |
| 2007 | 342.90 KRW | 6.15% |
| 2006 | 323.03 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 135.04 KRW | 802.6% |
| 2024 Q2 | 29.34 KRW | -78.27% |
| 2023 Q1 | 43.19 KRW | 170.78% |
| 2023 Q4 | -19.22 KRW | 84.99% |
| 2023 FY | - KRW | -336.64% |
| 2023 Q3 | -128.08 KRW | 58.6% |
| 2023 Q2 | -309.37 KRW | -816.3% |
| 2022 FY | - KRW | 328.71% |
| 2022 Q1 | 111.22 KRW | 160.94% |
| 2022 Q4 | -61.02 KRW | -184.86% |
| 2022 Q2 | 58.60 KRW | -47.31% |
| 2022 Q3 | 71.91 KRW | 22.71% |
| 2021 Q1 | 41.72 KRW | 120.92% |
| 2021 Q2 | 6.35 KRW | -84.78% |
| 2021 Q3 | 38.10 KRW | 500.0% |
| 2021 Q4 | -182.52 KRW | -579.06% |
| 2021 FY | - KRW | -174.17% |
| 2020 Q3 | 31.10 KRW | 125.04% |
| 2020 Q2 | 13.82 KRW | -94.01% |
| 2020 FY | - KRW | 144.06% |
| 2020 Q1 | 230.64 KRW | 903.34% |
| 2020 Q4 | -199.47 KRW | -741.38% |
| 2019 Q3 | 41.46 KRW | 111.85% |
| 2019 FY | - KRW | -317.35% |
| 2019 Q1 | 100.21 KRW | 379.24% |
| 2019 Q2 | -349.85 KRW | -449.12% |
| 2019 Q4 | -28.71 KRW | -169.25% |
| 2018 FY | - KRW | 99.39% |
| 2018 Q4 | 20.91 KRW | -65.71% |
| 2018 Q3 | 60.98 KRW | 388.05% |
| 2018 Q2 | -21.17 KRW | -143.1% |
| 2018 Q1 | 49.12 KRW | 226.08% |
| 2017 Q4 | -38.96 KRW | -195.68% |
| 2017 Q1 | 36.64 KRW | 80.23% |
| 2017 FY | - KRW | 44.69% |
| 2017 Q2 | 9.77 KRW | -73.34% |
| 2017 Q3 | 40.72 KRW | 316.79% |
| 2016 Q4 | 20.33 KRW | 338.34% |
| 2016 Q1 | 31.80 KRW | 108.27% |
| 2016 Q2 | -3.88 KRW | -112.2% |
| 2016 Q3 | -8.53 KRW | -119.85% |
| 2016 FY | - KRW | 112.81% |
| 2015 Q3 | -35.68 KRW | -156.8% |
| 2015 Q4 | -384.41 KRW | -977.38% |
| 2015 FY | - KRW | 15.66% |
| 2015 Q1 | 32.57 KRW | 108.07% |
| 2015 Q2 | 62.82 KRW | 92.88% |
| 2014 Q1 | -43.58 KRW | -135.89% |
| 2014 Q4 | -403.66 KRW | -809.79% |
| 2014 Q3 | 56.87 KRW | 1827.8% |
| 2014 Q2 | 2.95 KRW | 106.77% |
| 2014 FY | - KRW | -425.94% |
| 2013 Q1 | 17.21 KRW | 103.75% |
| 2013 FY | - KRW | 111.23% |
| 2013 Q3 | -48.05 KRW | -276.33% |
| 2013 Q4 | 121.43 KRW | 352.72% |
| 2013 Q2 | 27.25 KRW | 58.34% |
| 2012 Q4 | -459.00 KRW | -801.59% |
| 2012 FY | - KRW | -2132.4% |
| 2012 Q2 | -367.16 KRW | -218.91% |
| 2012 Q3 | -50.91 KRW | 86.13% |
| 2012 Q1 | -115.13 KRW | 0.0% |
| 2011 Q3 | 7.66 KRW | -26.63% |
| 2011 Q1 | 149.20 KRW | 650.13% |
| 2011 Q2 | 10.44 KRW | -93.0% |
| 2011 FY | - KRW | -79.71% |
| 2010 Q4 | 19.89 KRW | -47.37% |
| 2010 FY | - KRW | -37.68% |
| 2010 Q1 | 38.97 KRW | -68.06% |
| 2010 Q2 | 25.86 KRW | -33.64% |
| 2010 Q3 | 37.79 KRW | 46.13% |
| 2009 Q2 | 71.61 KRW | 81.98% |
| 2009 Q3 | 139.91 KRW | 95.38% |
| 2009 Q4 | 122.00 KRW | -12.8% |
| 2009 FY | - KRW | -1.07% |
| 2009 Q1 | 39.35 KRW | -70.04% |
| 2008 Q3 | 63.15 KRW | -49.5% |
| 2008 FY | - KRW | 8.67% |
| 2008 Q2 | 125.04 KRW | 98.89% |
| 2008 Q4 | 131.35 KRW | 108.0% |
| 2008 Q1 | 62.87 KRW | -13.89% |
| 2007 Q3 | 95.94 KRW | -5.65% |
| 2007 FY | - KRW | 6.15% |
| 2007 Q2 | 101.68 KRW | 0.0% |
| 2007 Q4 | 73.01 KRW | -23.9% |
| 2006 FY | - KRW | 0.0% |